Acetyl L-Carnitine (ALCAR) and ALS (Lou Gehrig's Disease)

. . . for a longer, higher-quality of life

A double-blind, placebo-controlled study has found that ALCAR has a significant impact on improving and prolonging life for those with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease.

ALS destroys motor neurons. While patients continue to see, hear, feel, touch and taste, they gradually lose control of their movements leading to paralysis and eventually death, usually due to respiratory failure. Average survival time after diagnosis is 2-5 years, although 5% will live 20 years, and there are some who have managed to halt and even reverse the process. The only medication shown to have some effect on ALS, riluzole, may increase survival time, but only by a matter of 3-5 months.

While ALS is a serious illness, remember that all disease is caused by deficiency and toxicity; therefore, there is much you can do to remedy and possibly even reverse the situation by taking control of your health.

ALCAR is called a “brain superfuel” for good reason. It can help anyone improve brain function, and has been shown to prolong life in mice with ALS and to regenerate nerve cells. Now a new study by Beghi et al. shows ALCAR can prolong and also improve the quality of life in humans with ALS. More than 80 patients were given riluzole along with either 3 grams a day of ALCAR or a placebo. At 48 weeks, those taking the ALCAR versus placebo had retained more self-sufficiency, functional ability and lung capacity. Median survival time was 45 months for the ALCAR group compared with 22 months for those taking the placebo.

It’s very important that an ALC product be extremely pure and that its molecules be in the correct biological form. There should be no solvent residues or D-carnitine present. Our Acetyl-L-Carnitinemeets these criteria; few others do. Other supplements that have proved helpful include B vitamins, Vitamin C and E, calcium, magnesium, milk thistle and curcumin. For more information call our office at 1-800-250-3063 and ask about our Brain Support Kit.

Beghi E. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal  Degeneration. February 2013. Epublished ahead of print. Accessed online May 26, 2013 at https://www.ncbi.nlm.nih.gov/pubmed/23421600

 ALS Association website at alsa.org. Accessed online May 26, 2013.

Kira Y. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice w/familial amyotrophic lateral sclerosis. Brain Research. January 27, 2006.  1070 (1):206-214.